WASHINGTON, September 14 — President Donald Trump has rejected a public appeal from the chief executives of Anthropic, OpenAI and xAI to slow the pace of artificial intelligence development, declaring that “whoever wins with AI wins.” The remarks, reported on Wednesday, put the White House squarely on the side of speed over precaution — and they land as a direct answer to three of the most prominent builders of advanced AI systems, who had jointly called for a slower, more careful approach to capability gains.
The appeal came from the top of the industry’s leading labs. Anthropic, founded in 2021 by former OpenAI executives including siblings Dario and Daniela Amodei, develops the Claude family of large language models and has built its identity around AI safety research.
OpenAI, founded in 2015 as a nonprofit and later restructured with a capped-profit arm, created ChatGPT in 2022 and the GPT series of models; its chief executive is Sam Altman. xAI, founded in 2023 by Elon Musk, develops the Grok chatbot and is integrated with the social media platform X. Their request to slow down was not a new position.
It reflects long-running debates over AI safety, alignment and the risks of rapid capability gains — arguments that have divided the industry even as its largest players race to ship more capable systems.
The policy backdrop
The president’s response aligns with a broader US posture that treats AI as a strategic technology in a competition with China. In recent years Washington has imposed export controls on advanced semiconductors and chipmaking equipment to China, citing national security concerns, and has sought to bolster domestic AI investment. That framing leaves little room for the kind of pause the three chief executives proposed.
Where safety advocates see risk that outpaces oversight, the administration sees a race in which standing still is the greater danger. The exchange also sits inside a wider global conversation about AI governance, a debate that has been running through international summits and regulatory efforts in recent years.
The White House has not released additional comment. What’s changing is who sets the tempo. Until now, the loudest calls for restraint have come from inside the labs themselves.
Now the political leadership has answered them directly — and the answer was no. The story is developing and further statements may follow. Watch this space.
